학술논문

The Impact of LEP rs7799039 Polymorphism and Obesity on the Severity of Coronavirus Disease-19
Document Type
Academic Journal
Source
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. February 28, 2023, Vol. 16, p515, 8 p.
Subject
Egypt
Language
English
ISSN
1178-7007
Abstract
Background and Aims: SARS-CoV-2 infection has been recorded in 230 countries to date. Obesity has a negative impact on one's quality of life and is one of the main causes of mortality globally. Obesity affects the immune system, making the host more susceptible to infectious infections. Also, obesity commonly provokes the severity of respiratory diseases so the correlation of LEP rs7799039 Polymorphism in corpulent patients with COVID-19 infection was clearly investigated in the current study. Methods: A total of 232 patients were recruited, 116 patients were obese with COVID-19 infection, and 116 patients were non obese COVID-19. Fasting blood glucose test (FBG), hemoglobin A1C (HbA1C), complete blood count (CBC), international normalized ratio (INR), urea, alanine transaminase (ALT), aspartate aminotransferase (AST), D dimer and C-reactive protein (CRP) were estimated. C.T. scan was performed for each patient, and C.T. severity score was calculated. Genotyping for the leptin rs7799039 SNPs was performed by TaqMan[R] (Applied Biosystems Step One TM Real-time PCR). Results: Regarding LEP polymorphism, all individuals of non-obese groups significantly had the homozygous allele GG (100%), whereas only 56% of obese groups had GG alleles (P = 0.001). The severity scores significantly (P = 0.001) varied regarding LEP polymorphism regarding Rs7799039, where the largest proportion of those with Grade IV had the homozygous allele AA (57.1%). Conclusion: There was a correlation between the leptin gene allelic discrimination and COVID-19 CT brutality in obese patients. The A allele was considered a risk factor for severity in COVID-19 patients while the G allele contributes to decreasing that risk. Keywords: COVID-19, leptin, gene polymorphism, immunity, obesity
Introduction A new coronavirus disease (COVID-19) was discovered in Wuhan, Hubei Province, China, in December 2019. (1,2) The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-instigated coronavirus disease 2019 (COVID-19) has [...]